Literature DB >> 1952874

Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.

A Iravani1.   

Abstract

A total of 108 college women with acute urinary tract infections were treated for 10 days with either 500 mg of cefprozil (BMY-28100-03-800) once a day (n = 72) or 250 mg of cefaclor three times a day (n = 36). Clinical and bacterial cure rates at 1 week posttherapy were 94 and 93%, respectively, for the cefprozil group and 94 and 94%, respectively, for the cefaclor group (P, not significant). Both cefprozil and cefaclor were safe and effective.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1952874      PMCID： PMC245300          DOI： 10.1128/AAC.35.9.1940

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Phase I study of multiple-dose cefprozil and comparison with cefaclor.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; R R Martin; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 3.  A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor.

Authors:  G D Sides; T R Franson; K A DeSante; H R Black
Journal:  Clin Ther       Date:  1988       Impact factor: 3.393

4.  Phase I study of single-dose BMY-28100, a new oral cephalosporin.

Authors:  R H Barbhaiya; C R Gleason; W C Shyu; R B Wilber; R R Martin; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

7.  A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.

Authors:  A Iravani; G A Richard; D Johnson; A Bryant
Journal:  Am J Med       Date:  1988-09-16       Impact factor: 4.965

8.  Treatment of acute uncomplicated urinary tract infections by cephalexin, with special reference to the antibody-coated bacteria.

Authors:  A Iravani; N Pryor; G A Richard
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-03

9.  Urinary tract infection caused by Staphylococcus saprophyticus.

Authors:  P A Jordan; A Iravani; G A Richard; H Baer
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

10.  Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infections.

Authors:  A Iravani; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191
View more
  1 in total

Review 1.  Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.

Authors:  L R Wiseman; P Benfield
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.